The Neuromodulation market in Asia Pacific is expected to grow from US$ 1,559.89 million in 2019 to US$ 3,518.34 million by 2027. This represents a CAGR of 11.0% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to increasing incidence of neurological disorders, growing developments in neuromodulation technology are projected to drive the Asia Pacific neuromodulation market during the forecast period. The India has observed fast growth in the neuromodulation market within the past few years and is expected to lead the market in Asia Pacific during the forecast period. Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation
India Neuromodulation Market Revenue and Forecast to 2027 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
ASIA PACIFIC NEUROMODULATION – MARKET SEGMENTATION
By Technology
- External (Non-Invasive) Neuromodulation
- Respiratory Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Internal Neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
By Application
- Chronic Pain Management
- Failed Back Syndrome
- Epilepsy
- Tremor
- Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson’s Disease
- Obsessive-Compulsive Disorder
- Migraine
By Country
- Japan
- China
- India
- South Korea
- Australia
By End User
- Hospitals
- Clinics
- Home Healthcare
By Country
- Japan
- China
- India
- South Korea
- Australia
- RoAPAC
Company Profiles
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
Asia Pacific Neuromodulation Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,559.89 Million |
| Market Size by 2027 | US$ 3,518.34 Million |
| Global CAGR (2020 - 2027) | 11.0% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Influenza Vaccines Market
- Thermal Energy Storage Market
- Biopharmaceutical Contract Manufacturing Market
- Sexual Wellness Market
- Battery Testing Equipment Market
- Adaptive Traffic Control System Market
- Explosion-Proof Equipment Market
- Smart Locks Market
- Enzymatic DNA Synthesis Market
- Dry Eye Products Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology Neuromodulation, Application, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Asia Pacific Neuromodulation Market
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
Get Free Sample For